Table 2.

Thrombotic effects of soybean-derived CGJ.

Model	Strain Used in Fermentation	Action Mode	Reference
Raw soybean	B. amyloliquefaciens MJ1-4	Repressing the growth of Aspergillus spp. producing aflatoxin B1 and Penicillium spp. producing ochratoxin by producing iturin or actively modified amino acids with 12,000–14,000 Da as a bacteriocin-like substance and another non-proteinaceous compound	[70]
Raw soybean	B. amyloliquefancies CH51	Producing fibrinolytic enzyme AprE51 similar to AprE homolog from B. subtilis	[71]
Raw soybean	B. subtilis 168	Improving fibrinolytic activity by genomic integration (amyE site) of aprE2, aprE176, and aprE179 gene	[72]
Raw soybean	B. subtilis CH3-5	Producing fibrinolytic enzyme AprE2 (29 kDa)	[74]
Raw soybean	B. subtilis HK176	Producing thermostable fibrinolytic enzyme AprE176	[73]
Raw soybean	B. amyloliquefaciens CH86-1	Producing fibrinolytic enzyme Bpr86-1	[75]
Raw soybean	B. amyloliquefaciens CB1	Producing fibrinolytic enzyme AprECB1 (28 kDa) as a serine metalloprotease in B. subtilis WB600; exhibiting the highest specificity for N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, known as a substrate	[76]
Male Sprague–Dawley rats	B. licheniformis ATCC1071	Activating a plasmin-like protease that degrades fibrin clots, but not plasminogen; inhibiting collagen-induced platelet aggregation	[67]